跳至主要内容
临床试验/ACTRN12610000740099
ACTRN12610000740099已完成未知

Measurement of anti-inflammatory resolvins and protectins in healthy individuals taking omega-3 fatty acids in combination with aspirin or placebo.

Professor Trevor Mori0 个研究点目标入组 20 人开始时间: 2010年9月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Blinded (masking used)

入排标准

年龄范围
20 Years 至 70 Years(—)
性别
All

入选标准

  • •Men aged 20-70 years, and post-menopausal women aged less than 70 years will be recruited from the general population by newspaper advertisements. Volunteers will be included if they do not meet any of the criteria for the metabolic syndrome as defined by the National Cholesterol Education Program Adult Treatment Panel III (NCEP: ATPIII).

排除标准

  • •Smokers, history of cardiovascular or peripheral vascular disease, diabetes, renal disease, liver disease or taking anti-hypertensive agents, lipid lowering drugs, hormone replacement therapy (women only), > 2 standard alcoholic drinks for women and >3 standard alcoholic drinks for men per day, aspirin or non-steroidal anti-inflammatory drugs, omega-3 fatty acids or >2 fish meals per week.

研究者

发起方
Professor Trevor Mori

相似试验